BACKGROUND: Brown adipose tissue (BAT) is involved in the regulation of whole-body energy expenditure and adiposity. The activity and prevalence of BAT decrease with age in humans. OBJECTIVE: To examine the effects of single nucleotide polymorphisms of the genes for uncoupling protein 1 (UCP1) and b3-adrenergic receptor (b3AR), key molecules of BAT thermogenesis, on age-related decline of BAT activity and accumulation of body fat in humans. METHODS: One hundred ninety-nine healthy volunteers (20-72 years old (y.o.)) underwent fluorodeoxyglucose-positron emission tomography (FDG-PET) and computed tomography (CT) after 2-h cold exposure to assess BAT activity. The visceral and subcutaneous fat areas at the abdominal level were estimated from the CT images. They were genotyped for À 3826 A/G polymorphism of the UCP1 gene and 64 Trp/Arg mutation of the b3AR gene. RESULTS: BAT was detected in 88 subjects out of 199 (44%), more in younger (p30 y.o., 55%) than older subjects (440 y.o., 15%). BAT prevalence of older subjects tended to be lower in the UCP1 G/G group than the A allele group (A/A and A/G), and also in the b3AR Arg allele group (Trp/Arg and Arg/Arg) than the Trp/Trp group. When compared subjects who had two or more base substitutions on the two genes (the 2-4 allele group) with those who had less than two base substitutions (the 0-1 allele group), BAT prevalence was comparable in younger subjects (62% vs 50%) but lower in older subjects (0% vs 24%, Po0.05). Visceral fat area of the 2-4 allele group was higher than that of the 0-1 allele group (Po0.05) in older subjects, but not in younger subjects. CONCLUSION: UCP1 À 3826 A/G and b3AR 64 Trp/Arg substitutions accelerate age-related decrease in BAT activity, and thereby may associate with visceral fat accumulation with age.
INTRODUCTION
It is well established in small rodents that brown adipose tissue (BAT) is the major site of the non-shivering thermogenesis, and contributes to control of body temperature and adiposity. 1, 2 Although the presence and activity of BAT in humans has been debated, recent studies using fluorodeoxyglucose-positron emission tomography (FDG-PET) in combination with computed tomography (CT) revealed adult humans have significant amounts of metabolically active BAT. [3] [4] [5] [6] [7] [8] [9] We and other groups demonstrated that BAT is activated by acute cold exposure 8, 9 and contributes to cold-induced thermogenesis. 10, 11 BAT activity is inversely related to body fat content, and decreases with age, [7] [8] [9] being associated with age-related accumulation of body fat. 12 Thus it seems now accepted that BAT contributes to the control of who-body energy expenditure and adiposity in humans, as in small rodents. However, there has been no report about the mechanisms and factors involving in the age-related reduction of BAT activity.
BAT thermogenesis is primarily dependent on uncoupling protein 1 (UCP1), an mitochondrial membrane protein which uncouples oxidative phosphorylation to produce heat instead of ATP. UCP1 expression and activity are mainly controlled by the smpathetic nervous system via b3-adrenergic receptor (b3AR). 13 Single nucleotide polymorphisms are known in the UCP1 and b3AR genes, UCP1 À 3826 A/G [14] [15] [16] and b3AR 64 Trp/Arg. 17, 18 There have been reports suggesting that UCP1 À 3826 A/G and b3AR 64 Trp/Arg polymorphisms act independently and/or synergistically to lower resting energy expenditure and also to decreased cold-induced and postprandial thermogenesis. [19] [20] [21] [22] Moreover, these polymorphisms are reported to be associated with body fat accumulation and also the effectiveness of low calorie diet therapy in obese subjects. 16, 17, 23, 24 To clarify whether the polymorphisms affect BAT activity, in the present study, we examined the effects of UCP1 À 3826 A/G and b3AR 64 Trp/Arg polymorphisms on the BAT activity assessed by FDG-PET/CT, with special reference to its age-releted changes. This is a first report of the effects of gene polymorphisms on BAT in healthy humans.
SUBJECTS AND METHODS
Two hundreds and twenty-three healthy volunteers aged 20-72 years, who had been living in Sapporo for more than 3 years, were recruited. Participants were carefully instructed regarding the study and gave their informed consent to participate.
All subjects underwent a standardized health examination and FDG-PET/ CT in winter (January-March) of 2007-2012. Twenty-four subjects were 1 excluded because their DNA samples were not taken, then data of 199 subjects were used for analysis (Table 1) . The protocol was approved by the institutional review boards of Tenshi College.
Fluorodeoxyglucose-positron emission tomography and computed tomography After fasting for 6-12 h, the subjects entered an air-conditioned room at 19 1C with light clothing (usually a T-shirt with underwear), and intermittently (usually for 4 min every 5 min) put their feet on an ice block wrapped in cloth. After 1 h under this cold condition, they were given an intravenous injection of 18 F-fluoro-2-deoxyglucose (FDG) (1.66-5.18 MBq kg À 1 body weight) and maintained under the same cold conditions. One hour after the 18 F-FDG injection, positron emission tomography(PET)/CT scans were performed employing a PET/CT system (Aquiduo, Toshiba Medical Systems, Otawara, Japan) in a room at 24 1C.
With the CT parameters of 120 kV and real-exposure control, unenhanced low-dose spiral axial 2-mm collimated images were obtained. They were used for PET attenuation correction as well as anatomic localization. Subsequently, full-ring PET was performed in six incremental table positions, each B15 cm in thickness. The total time for these scans was B30 min.
PET and CT images were coregistered and analyzed using a VOX-BASE workstation (J-MAC System, Sapporo, Japan). Two experienced, blinded observers assessed the FDG uptake, particularly on both sides of the neck and paravertebral regions, by visually judging the presence (BAT-positive) or absence (BAT-negative) of radioactivity greater than that of the background.
Anthropometric and body fat measurement
The body mass index (BMI) was calculated as the body weight in kilograms divided by the square of the height in meters (kg m À 2 ). The visceral and subcutaneous fat areas at the abdominal level of L4-L5 were estimated from the CT images. 25 The abdominal fat area was calculated as the sum of the visceral and subcutaneous fat areas.
Analysis of UCP1 and b3AR gene polymorphisms DNA was isolated from buccal mucosa cells collected using cotton swab, and analyzed by a PCR-sequence-specific oligonucleotide technique coupled with Luminex's xMAP technology (Luminex Japan, Tokyo, Japan) for the genotyping of the -3826 A/G polymorphism of UCP1 (rs1800592) and 64 Trp/Arg polymorphism of b3AR (rs4994). Briefly, multiplex-PCR was performed in 30-ml volumes containing 1 Â PCR buffer (80 mM Tris-HCl, 20 mM (NH 4 ) 2 SO 4 , 2 mM MgCl 2 , pH 9.0), 0.4 mM dNTPs, 7.5% Glycerol, 2.5 U Taq polymerase, 5 ml of template DNA and 0.4 mM primers labeled with biotin at 5 0 end, UCP1 forward 5
0 . The cycling condition was as follows: 93 1C for 3 min, then 40 cycles of 93 1C for 30 s, 65 1C for 1 min, and 72 1C for 1 min. The 5 0 -biotin-labeled PCR amplicons were then hybridized to sequence-specific oligonucleotide probes, which were designed to include corresponding polymorphic sites and covalently immobilized to the xMAP microspheres, and labeled with streptavidin-R-phycoerythrin simultaneously at 50 1C for 30 min. Followed by washing to remove unbound SAPE streptavidin-R-phycoerythrin, fluorescence signals from each microsphere was detected with the Luminex instrument. Genotype of each polymorphism was determined according to the median fluorescence intensity of each microspheres.
Data analysis
Statistical analysis was performed with the use of a statistical software package (SPSS 18.0 for Windows, IBM Japan, Tokyo, Japan). Continuous variables and categorical variables were summarized as means±s.e.m. and proportions, respectively. Hardy-Weinberg equilibrium was evaluated using a w 2 goodness-of-fit test. Differences between groups of subjects were analyzed using one-factor or two-factor analysis of variance with Bonferroni multiple comparison procedure (two-side P values were given), and Fisher's exact test (one-side P values were given), as appropriate. Logistic regression analysis with adjustment for age, sex and BMI was also used to assess the associations between the gene polymorphisms and BAT. The significance of interactions of age with the gene polymorphisms on BAT was assessed by adding a cross-product term to the logistic regression model. P value of less than 0.05 was considered as statistically significant.
RESULTS
FDG-PET/CT revealed that 88 subjects were BAT-positive, showing detectable FDG uptake in the supracravicular adipose tissue, while 111 subjects were BAT-negative, BAT prevalence being 44.2% (Table 1 ). The allele frequencies of UCP1 À 3826 A and G were 0.508 and 0.492, and those of b3AR 64 Trp and Arg were 0.784 and 0.216, respectively. The genotype frequencies of UCP1 A/A, A/G and G/G were 0.270, 0.475 and 0.255, respectively, and those of b3AR Trp/Trp, Trp/Arg and Arg/Arg were 0.620, 0.330 and 0.050, respectively. These genotype frequencies were in Hardy-Weinberg equilibrium. There were no differences in BAT prevalence among the genotypes of UCP1 and also of b3AR. No differences were also found in BMI and abdominal fat area among the genotypes.
We previously reported that the BAT prevalence markedly decresed with age. 12 To investigete the effects of UCP1 and b3AR gene polymorphisms on the age-related decrease in BAT prevalence, subjects were divided into three groups by age, younger subjects of 20-30 years old (y.o.), middle-aged subjects of 31-40 y.o., and older subjects of 40-72 y.o.. BAT prevalence significantly decreased with age ( Figure 1a ). The subjects with UCP1 A/A and A/G were pooled as A allele group because of a small number of older subjects. The number and mean age of the UCP1 A allele group were 148 and 31.2±1.0 y.o., and those of the G/G group were 51 and 30.8 ± 1.7 y.o.. The subjects with b3AR Trp/ Arg and Arg/Arg were also pooled as Arg allele group. The number The BAT prevalence of the UCP1 G/G group was almost the same as that of the A allele group in younger and middle-aged subjects (Figure 1b) . In older subjects, the BAT prevalence of the G/G group (0%) tended to be lower than that of the A allele group (19%), although the difference did not reach statistically significant levels.
The BAT prevalence of the b3AR Arg allele group was comparable with that of the Trp/Trp group in younger subjects (Figure 1c ). When compared with younger subjects, the BAT prevelence of middle-aged subjects significantly decreased in the Arg allele group, but not in the Trp/Trp group. In older subjects, the BAT prevalence of the Arg allele group (7%) tended to be lower than that of the Trp/Trp group (19%), although the difference was not statistically significant.
To estimate the cumulative effect of the two variants, the sum of the number of G and Arg alleles was counted in each subject (Table 2) , and divided into two groups; 0-1 allele group (N ¼ 110) and 2-4 allele group (N ¼ 89). There was no difference between the two groups in BAT prevalence (42% vs 47%), age (31.1 ± 1.1 vs 31.1 ± 1.2 y.o.) and BMI (21.6 ± 0.3 vs 22.2 ± 0.3 kg m À 2 ). The BAT prevalence of the two groups showed no differences in younger subjects (Figure 1d) . In older subjects, however, the BAT prevalence of the 2-4 allele group (0%) was significantly lower than that of the 0-1 allele group (24%, Po0.05), while there was no difference in age between the groups (51.9±2.6 vs 49.6±1.4 y.o.).
Furthermore, we estimated independent and additional effects of these gene polymorphisms on BAT by logistic regression analysis. As summarized in Table 3 , in univariate analysis, no significant association was found between these polymorphisms and BAT. However, multivariate analysis with adjustment for age, sex and BMI revealed a significant interaction between age and the number of G and Arg alleles (P ¼ 0.04), suggesting that these polymorphisms are related to reduced BAT with age.
We also compared the adiposity-related paramaters among the groups stratified by the genotype of UCP1 and b3AR gene polymorphisms. There were no significant differences in BMI, abdominal fat, visceral, subcutaneous fat areas between the UCP1 A allele and G/G groups, between the b3AR Trp/Trp and Arg allele groups, and also between the 0-1 allele and 2-4 allele groups (data not shown).
BMI, abdominal, visceral and subcutaneous fat areas significantly increased with age (Figures 2a, e, i and m) . These parameters of the UCP1 G/G group were almost the same as those of the A allele group in younger subjects, increased with age, and in older subjects were higher than those of the A allele group (Figures 2b, f, j and n) . The adiposity-related parameters of the b3AR Arg allele group were almost the same as that of the Trp/ Trp group, but in older subjects visceral fat area of the Arg allele group (80.2 ± 11.4 cm 2 ) was insignificantly higher than that of the Trp/Trp group (68.3±6.3 cm 2 ) (Figures 2c, g, k and o) . When compared the adiposity-related parameters between the 0-1 allele and 2-4 allele groups, no difference was found between the two groups in younger subjects (Figures 2d, h, l and p) . However, in older subjects, visceral fat area of the 2-4 allele group (88.4±10.0 kg m À 2 ) was significantly higher than that of the 0-1 allele group (62.1 ± 6.0 kg m À 2 , Po0.05). Similar differences between the groups were found in BMI (24.2 ± 0.9 kg m À 2 , 22.6±0.6 kg m À 2 ) and abdominal fat area (271.1±28.4 cm 2 , 219.4 ± 17.8 cm 2 ), although they did not reach statistically significant levels.
DISCUSSION
As reported previously, 8 the metabolic activity of BAT can be assessed by FDG-PET/CT conducted after acute cold exposure at 19 1C. In the present study, we applied this method for the detection of BAT in adult volunteers. Being consistent with our previous results, 8, 10, 12 cold-activated BAT was detected in about a half of the younger subjects. We also reported that BAT prevalence markedly decreased and adiposity increased with age in 162 healthy subjects. 12 This was confirmed in the present study when combining the data from newly recruited 37 subjects and our previous study. To investigate the possible involvement of genetic factors in BAT activity, we analyzed the effects of polymorphsms of the two genes, UCP1 and b3AR, on the BAT prevalence.
The analysis for all subjects as a whole revealed no effect of UCP1 À 3826 A/G and b3AR 64 Trp/Arg on the BAT prevalence. However, BAT prevalence tended to decrease with age more rapidly in the UCP1 G/G and b3AR Arg allele groups than the A allele and Trp/Trp groups, respectively. Although the individual effects of UCP1 G/G and b3AR Arg allele on BAT prevelence were not statistically significant, it was found that the carrying number of UCP1 G and b3AR Arg alleles significantly affects on the agerelated decrease in BAT prevalence; that is, higher frequency of G and Arg alleles (2-4 alleles) accelerates the age-related decrease in BAT prevalence.
Recently, Rose et al. 26 reported that UCP1 À 3826 A to G variant shows lower promoter activity of the UCP1 gene. The G allele of the UCP1 gene is also associated with lower expression levels of UCP1 mRNA in intraperitoneal adipose tissue. 27 Moreover, Lee et al. 28 reported that PET-negative supraclavicular fat showed notably lower expression levels of UCP1 compared with PETpositive supraclavicular fat. Taken together, it is highly likely that UCP1 À 3826 G is an allele responsible for lower prevalence/ activity of BAT in aged humans.
It seems also possible that b3AR 64 Trp/Arg affects BAT prevalence/activity. Cold-induced activation of BAT is under direct control of the sympathetic nerves-b-adrenergic receptor system. 1, 13 The responsiveness of the system and thermogenic capasity of BAT diminish with age whereas neural signaling to BAT is intact, 29 suggesting that age-related decline of BAT is attributable, at least in part, to the decrease in the responsiveness of b3AR to noradrenerine. In addition, b3AR 64 Trp/Arg polymorphism is known to bring about lower responses of b3AR to noradrenaline stimulation. 30 Collectively, b3AR 64 Trp to Arg variation seems to be an additional allele responsible for lower BAT prevalence/activity in aged humans.
As noted above, UCP1 À 3826 A/G and b3AR 64 Trp/Arg may individually affect BAT activity. In the present study, however, the effects of these two polymorphisms on BAT prevalence did not reach statistically significant levels, suggesting that each effect was too weak to be detected, particularly in small sample sizes. In fact, an analysis focusing on combined impact of G and Arg alleles revealed that higher frequency of G and Arg alleles (2-4 alleles) accelerates age-related decrease in BAT prevalence. These findings suggest the synergistic effects of the two gene polymorphisms on the age-related decrease in BAT prevalence/ activity.
In the present study, an analysis for all subjects as a whole revealed no effect of UCP1 À 3826 A/G and b3AR 64 Trp/Arg on adiposity-related parameters. However, in older subjects (440 years), those with UCP1 G/G showed significantly higher BMI, abdominal and visceral fat areas than those with A allele. There have been conflicting reports on the relation between UCP1 G allele and adiposity. Some studies repoted the association of G allele with obesity, whereas others did not confirm this. [31] [32] [33] [34] Such discrepancy may be owing to analysis without having to take into consideration of possible effects of age-related decline of BAT on obesity development. In fact, the data obtained from old volunteers/patients revealed significant association of UCP1 À 3826 A/G with BMI, 31, 32 but those from young subjects showed no association. 33, 34 Being consistent these previous reports, our present results demonstrated an impact of the UCP1 gene polymorphism on adiposity-related parameters in older, but not younger, subjects.
As reported in large scale studies, 35 we found no difference in BMI and abdominal fat area between the b3AR 64 Trp/Trp and Arg allele groups, although a slitght and insignificant effect on visceral fat area was observed in older subjects. However, we found the cumulative effects of UCP1 G and b3AR Arg alleles on visceral fat area: that is, higher frequency of G and Arg alleles (2-4 alleles) Abbreviations: CI, confidence interval; OR, odds ratio. Adjusted OR was calculated by logistic regression with adjustment for age, sex and BMI. Subjects were divided into 3 groups corresponding to the lower, middle and upper thirds of the values for age and BMI, and coded as 1, 2 and 3. They were also divided into 2 groups corresponding to the genotypes of UCP1, b3AR or the number of substitutions of G and Arg alleles, and coded as 0 (the A allele, Trp/Trp, 0-1 groups) and 1 (the G/G, Arg allele, 2-4 groups). The cross-product terms of the categorized variables were added to the logistic regression model to assess the interaction of age and the gene polymorphisms.
Human brown adipose tissue and SNP T Yoneshiro et al accelerates age-related accumulation of visceral fat. As noted above, similar cumulative effects of UCP1 G and b3AR Arg alleles were also found in the age-related decrease in BAT. All these results are well compatible with the idea that decreased BAT activity is associated with accumulation of body fat with age.
In conclusion, our results indicate that UCP1 À 3826 A/G and b3AR 64 Trp/Arg gene polymorphisms contribute, at least in part, to age-related decrease in BAT activity, and thereby to body fat accumulation. 
